By Jonathan Stempel NEW YORK, July 13 (Reuters) – A federal appeals court on Monday revived more than 500 private lawsuits against Tylenol maker Kenvue over the painkiller's alleged link to autism.
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)